SKYE - Emerald Health Skye Bioscience merger gets court approval in Canada

• Emerald Health Therapeutics ( OTCQB:EMHTF ) said the Supreme Court of British Columbia approved the company's merger with Skye Bioscience ( OTCQB:SKYE ).
• In May, Canadian medical cannabis company Emerald and San Diego-based Skye announced a merger via share-for-share-transaction. The combined company would  operate under the name Skye Bioscience, Skye stockholders would own 54% stake , while Emerald shareholders would own the remaining 46% in the company.
• Emerald said in an Aug. 26 press release that the Arrangement was approved by its shareholders on Aug. 19.
• Completion of the transaction, remains subject to approval from Skye shareholders, which is expected to be obtained at a meeting to be held no later than Oct. 4, noted Emerald.
• The transaction is expected to close by Oct. 15, subject to Skye getting listing approval from the Canadian Securities Exchange and other customary conditions.

For further details see: